Eschenbach et al., 2000 - Google Patents
Influence of the normal menstrual cycle on vaginal tissue, discharge, and microfloraEschenbach et al., 2000
View PDF- Document ID
- 6304477983575097322
- Author
- Eschenbach D
- Thwin S
- Patton D
- Hooton T
- Stapleton A
- Agnew K
- Winter C
- Meier A
- Stamm W
- Publication year
- Publication venue
- Clinical Infectious Diseases
External Links
Snippet
The objective of this study was to examine genital tissue, vaginal fluid, and vaginal microbial flora at 3 phases of the menstrual cycle in asymptomatic women. Vaginal examinations were performed 3 times in 74 women: at the menstrual phase (days 1–5), the preovulatory phase …
- 230000027758 ovulation cycle 0 title abstract description 64
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Eschenbach et al. | Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora | |
Gupta et al. | Effects of contraceptive method on the vaginal microbial flora: a prospective evaluation | |
Van De Wijgert et al. | Intravaginal practices, vaginal flora disturbances, and acquisition of sexually transmitted diseases in Zimbabwean women | |
Wang et al. | The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1 | |
Reiter et al. | Bacterial vaginosis: a primer for clinicians | |
Miller et al. | Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium | |
Marrazzo et al. | Risk factors for cervicitis among women with bacterial vaginosis | |
Boskey et al. | Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification | |
Eschenbach et al. | Effects of vaginal intercourse with and without a condom on vaginal flora and vaginal epithelium | |
Bradshaw et al. | Higher-risk behavioral practices associated with bacterial vaginosis compared with vaginal candidiasis | |
Ness et al. | Bacterial vaginosis and risk of pelvic inflammatory disease | |
Raz et al. | Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women | |
Hillebrand et al. | Urinary tract infections in pregnant women with bacterial vaginosis | |
O'Loughlin et al. | Safety, tolerability, and pharmacokinetics of SPL7013 gel (VivaGel®): a dose ranging, phase I study | |
Manhart et al. | Mucopurulent cervicitis and Mycoplasma genitalium | |
Wiesenfeld et al. | Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection | |
Mostad et al. | Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina | |
Verstraelen et al. | Bacterial vaginosis: an update on diagnosis and treatment | |
Ness et al. | Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina | |
Brunham et al. | Mucopurulent cervicitis—the ignored counterpart in women of urethritis in men | |
Cherpes et al. | Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization | |
Harmanli et al. | Urinary tract infections in women with bacterial vaginosis | |
Beigi et al. | Factors associated with absence of H2O2-producing Lactobacillus among women with bacterial vaginosis | |
Cone | Vaginal microbiota and sexually transmitted infections that may influence transmission of cell-associated HIV | |
Eschenbach et al. | Effects of oral contraceptive pill use on vaginal flora and vaginal epithelium |